Few Lynch syndrome patients take aspirin for cancer prevention, despite promising lower-dose evidence
A German survey of 539 individuals with Lynch syndrome found that under one in ten reported taking acetylsalicylic acid to lower their cancer risk, even though many were open to preventive options. Earlier research had shown that a 600 mg daily dose reduced colorectal cancer incidence in this inherited high-risk group. A newer international trial indicates that 100 mg daily may provide comparable protection with fewer bleeding problems, although the authors caution that statistical equivalence was not confirmed in every analysis.
...
... No extra. Plain text. Need maybe two paragraphs in EXPANDED. Under 120 words total. We have 119. Good. But check "The German LYNX survey" Is LYNX mentioned in material? It says "The results of the LYNX study thus..." Yes. Good. "queried" okay. "between December 2025 and February 2026" from material. "before CaPP3 appeared" okay. "97% knew screening recommendations" source "About 97% of respondents are familiar with specific screening recommendations". Good. "nearly all had regular colonoscopies" source "nearly all undergo regular colonoscopies." Good. "10.4% reported current aspirin use" source "only 10.4% reported currently taking acetylsalicylic acid." Good. "6.9% took it specifically to reduce cancer risk" source "Only 6.9% ... specifically used acetylsalicylic acid for cancer prevention in Lynch syndrome." Good. "Respondents cited limited prior consideration, side-effect worries, and unclear evidence." Source reasons: lack prior engagement, concerns side effects, uncertainty sc